# Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

> **NCT06855667** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 50 (estimated)

## Conditions studied

- Autoimmune Hepatitis

## Interventions

- **BIOLOGICAL:** Plasma Exchange
- **DRUG:** Steroid
- **DIETARY_SUPPLEMENT:** Diet

## Key facts

- **NCT ID:** NCT06855667
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855667, "Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06855667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*